cIMPACT-NOW Update 3: Recommended Diagnostic Criteria for “Diffuse Astrocytic Glioma, IDH-wildtype, With Molecular Features of Glioblastoma, WHO Grade IV”

Acta Neuropathologica - Germany
doi 10.1007/s00401-018-1913-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Predictive MGMT Status in a Homogeneous Cohort of IDH Wildtype Glioblastoma Patients

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2019English

A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain

PLoS ONE
Multidisciplinary
2016English

cIMPACT ‐ NOW : A Practical Summary of Diagnostic Points From Round 1 Updates

Brain Pathology
Forensic MedicineNeurosciencePathologyNeurology
2019English

Overexpression of Multiple Oncogenes Related to Histological Grade of Astrocytic Glioma

British Journal of Cancer
Cancer ResearchOncology
1992English

Imaging Correlates for the 2016 Update on WHO Classification of Grade II/III Gliomas: Implications for IDH, 1p/19q and ATRX Status

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

Equivalence of BCSH and WHO Diagnostic Criteria for ET

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

Age-Specific Genome-Wide Association Study in Glioblastoma Identifies Increased Proportion of ‘Lower Grade Glioma’-Like Features Associated With Younger Age

International Journal of Cancer
Cancer ResearchOncology
2018English

Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma—an Update of Its Clinicopathological Features and Molecular Biology

Critical Reviews in Oncology/Hematology
GerontologyGeriatricsHematologyOncology
2015English

Diagnostic Impact of the 2016 Revised Who Criteria for Polycythemia Vera

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy